ArticleCirculation reports2025
Advancing Scientific Cardiac Rehabilitation - Retrospect and Prospect.
Article in Circulation reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Unraveling the Cardiorenal Nexus - Emerging Frameworks and the Role of Exercise Therapy.Circulation reports · 2026Review
- Implementation and Challenges of Early-Phase Physiotherapy During Cardiovascular Intensive Care.Circulation reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
On the 30th anniversary of the founding of the Japanese Association of Cardiac Rehabilitation in 1995, this article provides an overview of the past and future of cardiac rehabilitation (CR) as science. The development of CR thus far has undoubtedly been supported not only by clinical needs but also by numerous pieces of scientific evidence regarding its effectiveness. In the first part of this article, I aim to scrutinize past evidence on CR scientifically, because all evidence must be critically examined. In the latter part, I will look ahead to the future of CR. Recently, there has been a rapid increase in very elderly frail patients with multiple comorbidities. In the near future, treatment for these patients will not be completed with acute-phase interventions targeting a single organ, and hence, patient outcome goals are expected to shift from improving survival prognosis to improving physical activity capacity and quality of life, indicating a growing need for CR like never before. Given the current rise in patients in the area where evidence is lacking, a new evidence-based CR that is not simply an extension of traditional practices is required. Taking into account the changes in the times, we must steadfastly pursue scientific CR by creating new evidence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.